Higher Risk of Adverse Events When Biologic Infusions Are Done at Home
Injection Pen May Reduce Injection Fear Among RA Patients Taking Etanercept Biosimilar
The Race Is On: Clinical Trials Begin for Agents Biosimilar to Denosumab
Secukinumab Effective Across the Spectrum of Psoriatic Arthritis
When Switching Patients to Biosimilars, Communication & Expert Nurses Reduce the Nocebo Effect
New Clinical Trials for Ustekinumab & Denosumab Biosimilars Begin Recruitment
Health Canada Approves CT-P13 SC for RA; Plus Tofacitinib May Increase Cardiac & Cancer Risks
UnitedHealthcare Designates Avsola, Inflectra Preferred Infliximab Products
FDA Approves New Rituximab Biosimilar & Anakinra to Treat a Rare Disease
- 1
- 2
- 3
- …
- 33
- Next Page »